Successfully Launching New Pharma Products with the Aid of a Go to Market Entry Strategy – An Infiniti Research Case Study
LONDON--(BUSINESS WIRE)--Dec 3, 2018--Infiniti Research, a global market and strategic intelligence solutions provider, has announced the completion of their . The client is one of the well-known American specialty pharmacies in the United States.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181203005514/en/
Go to market strategy for an American pharmaceutical company. (Graphic: Business Wire)
With the increased spend on oncology, diabetes, and autoimmune drugs, the pharmaceutical company was facing numerous challenges. This forced the client to expand their offerings by developing a new second-line of drugs. The primary aim of the company was to develop a go to market strategy template to launch their second-line drugs. Moreover, the client wanted to enhance market penetration, revenue, and profitability by aligning their company’s marketing strategies with commercial functions.
A go to market strategy is a pre-requisite for effective businesses planning, especially when it comes to launching a new product range or service. This strategy provides detailed insights on how an organization can pitch their products or services to their target users. Moreover, it helps analyze the importance of a specific product or a service by identifying the problems faced by customers. A well-planned go to market strategy helps businesses launch their products/services in an impactful manner.
According to the market entry experts at Infiniti Research, “An accurate go to market strategy addresses components such as market definition, value proposition, business goals, pricing strategies, distribution channels, and marketing objectives in a clear and concise manner.”
Infiniti Research’s go to market strategy helped the client to identify key growth and business expansion opportunities and balance near-term threats with their long-term business plans. This ensured the commercial success of second line drugs without hampering the market for existing drug lines. Moreover, with or help, the client was able to boost their profitability and market their second-line drugs to the right set of target audience.
Infiniti Research’s go to market strategy helped the client to:Increase their profit margins. Ensure the commercial success of second line drugs. To know how our go to market strategy is helping organizations gain an upper edge in niche markets,
Infiniti Research’s go to market strategy offered predictive insights on:Enhancing market penetration. Developing long-term business plans to ensure ongoing success. To know more about the impact of a go to market strategy when it comes to successful product launch,
About Infiniti Research
Established in 2003, is a leading market intelligence company providing smart solutions to address your business challenges. Infiniti Research studies markets in more than 100 countries to help analyze competitive activity, see beyond market disruptions, and develop intelligent business strategies. To know more, visit:
View source version on businesswire.com:https://www.businesswire.com/news/home/20181203005514/en/
CONTACT: Infiniti Research
US: +1 844 778 0600
UK: +44 203 893 3400
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Infiniti Research
Copyright Business Wire 2018.
PUB: 12/03/2018 08:46 AM/DISC: 12/03/2018 08:46 AM